New Seeking Alpha article | CORT Message Board Posts

Corcept Therapeutics Inc

  CORT website

CORT   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  2789 of 3139  at  9/13/2019 7:24:43 AM  by


The following message was updated on 9/13/2019 7:28:02 AM.

New Seeking Alpha article

The author tells that Corcept will face significant competition from Novartis (Signifor) and also Strongbridge Biopharma (Levoketoconazol) (which he seems to be invested in as he promoted SBBP a couple months ago).

Of course the subject here has been discussed many times. We all know where to stand regarding Signifor & Levoketoconazol. But as Alan has already said multiple times, here is a reminder why we think that CORT should still earn a big piece of the cake:

SBBP drug does not act directly on the diurnal rythm of cortisol, the drug tends to only suppress the Cortisol level without acting on the underlying issues.

An important biological aspect of Cortisol is that the level of Cortisol is highest when we wake up in the morning and then it drops through the day and then rises through the night. That is what makes Korlym and Relacorilant so unique as it helps to reestablish that diurnal cycle. Thatís one of the main reason so many patients do feel much better on Korlym.

Because of that Corcept will keep their impressive growth and market shares even though new competitors (SBBP) are slowly entering the market.

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 177
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Msg # Subject Author Recs Date Posted
2790 Re: New Seeking Alpha article KJDedge 1 9/13/2019 8:08:55 AM

About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 All rights reserved. User Agreement
Financial Market Data provided by